Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against chikungunya virus

Chikungunya virus (CHIKV) outbreaks have led to a serious economic burden, as the available treatment strategies can only alleviate disease symptoms, and no effective therapeutics or vaccines are currently available for human use. Here, we report the use of a new cost-effective approach involving pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Rothan, H.A., Bahrani, H., Shankar, E.M., Rahman, N.A., Yusof, R.
Format: Article
Language:English
Published: 2017
Tags: Add Tag
No Tags, Be the first to tag this record!